Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • a11msp
    Member
    • Jun 2010
    • 26

    #1

    A stats question about DESeq

    It may be a slightly outdated question now that GLM-based testing is preferred to the exact test, but I'm just very curious...

    In the 2010 Genome Biology paper (http://genomebiology.com/2010/11/10/r106), formula 14 describes how in the negative binomial test, variance of condition A is estimated under the null hypothesis of the equality of per-condition means:

    σˆ2_{A} = ∑{all_j∈A} [ s{j}*q0+s{j}ˆ2 * v{A}(q0) ],

    where:
    ∑{all_j∈A} is the sum across all samples in condition A,
    s{j} are scaling factors for each of these samples,
    q0 is the pooled mean estimate,
    v{A} is the raw variance estimate for condition A given the mean.

    However, looking at the DESeq code, I'm not sure v{A} is actually estimated based on q0. Rather, it seems to me it is estimated based on q{A} - the observed mean of counts for condition A.

    Am I getting it wrong or there have been some changes that I'm not aware of?

    Thanks very much!
  • Simon Anders
    Senior Member
    • Feb 2010
    • 995

    #2
    If I am still read my old code correctly, then the variance-mean relation for condition A is fitted by a local regression of the per-gene variances onto the mean of the counts only from condition A (in the code for the estimateDispersion method, 'if' clause for 'per-condition': bmv$baseMean, where bmv is calculated from only the columns for the current condition), but to get the fitted value, this function is then evaluated for the overall mean (in the code: overall_basemeans). This is consistent with what we wrote in the paper, I think.

    However, in DESeq2, we now dropped the "per-condition" mode, because it was a bit difficult to reconcile with our general improvements to the dispersion estimation.

    Comment

    • a11msp
      Member
      • Jun 2010
      • 26

      #3
      Thanks a lot for your reply Simon!

      Comment

      • a11msp
        Member
        • Jun 2010
        • 26

        #4
        Sorry, one more question... Am I right then that for sharing mode == "maximum" and method == "per-condition", the maximum is computed between the fitted SCV given the overall mean and the observed SCV given the mean for a given condition?

        Many thanks!
        Last edited by a11msp; 10-15-2013, 08:02 AM.

        Comment

        • Simon Anders
          Senior Member
          • Feb 2010
          • 995

          #5
          Just looked through my code again. Yes, this is what I've put there. The reason, If I remember correctly, had something to do with the handling of zeroes.

          Comment

          • a11msp
            Member
            • Jun 2010
            • 26

            #6
            OK, thanks!

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
              by SEQadmin2



              CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

              Despite this, “CRISPR helped turn genome editing from a specialized technique into
              ...
              Yesterday, 11:01 AM
            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 02:55 AM
            0 responses
            12 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            12 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            13 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            24 views
            0 reactions
            Last Post SEQadmin2  
            Working...